Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book. If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines
Get up-to-the-minute Globe Business Updates   |  More Business News
	ADVERTISEMENT Monday, January 10, 2011 Genzyme says talks with Sanofi-Aventis expanded CAMBRIDGE -- Biotech drugmaker Genzyme Corp. said that talks between its financial advisers and those of suitor Sanofi-Aventis have expanded to include representatives from both companies. Fidelity unveils partnership with Teach For America Fidelity Investments, the Boston mutual funds giant, unveiled a partnership with Teach For America, a national nonprofit organization that enlists recent college graduates to teach in urban and rural public schools. The Patriots have an official frozen dessert Roba Dolce said its Italian gelato and sorbetto is now the �official frozen dessert of the New England Patriots� under a new agreement with the Kraft Sports Group. Boston Scientific receives $77m stent settlement Medical device maker Boston Scientific Corp. said it settled a patent dispute over stents with Israel-based Medinol Ltd. and will record a gain in the fourth quarter. Gas prices rise again The average price of gas in Massachusetts was $3.089 per gallon in the latest weekly AAA survey, up 2 cents from the previous week's average, AAA Southern New England said. Cubist Pharma sees 2010 revenue jump 13 percent Cubist Pharmaceuticals Inc. said its fourth quarter revenue fell 3 percent but its full year total was still up 13 percent. Global Novations plans Waltham relocation Global Novations, a talent development firm, has company signed a seven-year lease agreement and will relocate its headquarters from Brighton in Boston to 200 West St. in Waltham, said a broker involved in the transaction. T2 Biosystems moves to larger offices in Lexington T2 Biosystems Inc., a company that develops medical diagnostic products, said that it has relocated to a newly renovated 20,000 square foot facility in Lexington. Neuroptix closes C round financing Neuroptix Corp. said that it has closed the first approximately $4 million tranche of a Series C funding round as it continues clinical development of its diagnostic platform. Epizyme allies with GlaxoSmithKline Epizyme, a Cambridge life sciences company, announced a worldwide strategic alliance with GlaxoSmithKline, a large drug maker, that will result in Epizyme receiving a $20 million up-front payment. Civitas Therapeutics secures $20m Civitas Therapeutics Inc., a Chelsea-based biopharmaceutical company, announced today that it has secured a $20 million Series A financing from founding investor, Longitude Capital, along with co-lead Canaan Partners. AMAG provides business update AMAG Pharmaceuticals Inc., a Lexington biopharmaceutical company, has issued preliminary fourth quarter 2010 financial estimates and financial guidance for 2011.